State Board of Administration of Florida Retirement System Has $1.05 Million Position in Phibro Animal Health Co. (NASDAQ:PAHC)

State Board of Administration of Florida Retirement System cut its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC – Get Rating) by 22.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 78,284 shares of the company’s stock after selling 22,335 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Phibro Animal Health were worth $1,050,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Gladius Capital Management LP increased its holdings in shares of Phibro Animal Health by 25.8% during the 4th quarter. Gladius Capital Management LP now owns 3,088 shares of the company’s stock worth $42,000 after acquiring an additional 634 shares during the last quarter. UBS Group AG boosted its stake in Phibro Animal Health by 3,713.7% in the 3rd quarter. UBS Group AG now owns 4,462 shares of the company’s stock valued at $59,000 after purchasing an additional 4,345 shares during the period. Teachers Retirement System of The State of Kentucky bought a new stake in Phibro Animal Health in the 3rd quarter valued at $71,000. Tower Research Capital LLC TRC boosted its stake in Phibro Animal Health by 430.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 5,378 shares of the company’s stock valued at $71,000 after purchasing an additional 4,364 shares during the period. Finally, First Republic Investment Management Inc. bought a new stake in Phibro Animal Health in the 1st quarter valued at $248,000. 49.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently issued reports on PAHC. StockNews.com began coverage on Phibro Animal Health in a research note on Thursday, March 16th. They issued a “hold” rating for the company. Morgan Stanley reduced their price target on Phibro Animal Health from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Thursday, February 9th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and an average price target of $18.00.

Phibro Animal Health Stock Performance

PAHC opened at $14.42 on Tuesday. The firm has a market cap of $584.05 million, a P/E ratio of 20.31, a price-to-earnings-growth ratio of 7.73 and a beta of 0.61. Phibro Animal Health Co. has a 52-week low of $11.75 and a 52-week high of $20.54. The company has a debt-to-equity ratio of 1.71, a quick ratio of 1.77 and a current ratio of 3.54. The business’s fifty day moving average is $15.10 and its 200-day moving average is $14.57.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 28th. Stockholders of record on Wednesday, June 7th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 3.33%. The ex-dividend date of this dividend is Tuesday, June 6th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 67.61%.

Phibro Animal Health Company Profile

(Get Rating)

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines.